BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 35177562)

  • 1. Sex-Specific U-Shaped Relationships Between High-Density Lipoprotein Cholesterol Levels and 10-year Major Adverse Cardiovascular Events: A Nationwide Cohort Study of 5.7 Million South Koreans.
    Yang HS; Jeong HJ; Kim H; Hwang HK; Hur M; Lee S
    Ann Lab Med; 2022 Jul; 42(4):415-427. PubMed ID: 35177562
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sex-Specific Relationships between HDL-Cholesterol Levels and 10-Year Mortality in Individuals with Atherosclerotic Cardiovascular Disease: A Nationwide Cohort Study of South Koreans.
    Yang HS; Jeong HJ; Kim H; Lee S; Hur M
    Metabolites; 2023 Nov; 13(12):. PubMed ID: 38132858
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study.
    Downs JR; Clearfield M; Weis S; Whitney E; Shapiro DR; Beere PA; Langendorfer A; Stein EA; Kruyer W; Gotto AM
    JAMA; 1998 May; 279(20):1615-22. PubMed ID: 9613910
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipoprotein lipids in older people. Results from the Cardiovascular Health Study. The CHS Collaborative Research Group.
    Ettinger WH; Wahl PW; Kuller LH; Bush TL; Tracy RP; Manolio TA; Borhani NO; Wong ND; O'Leary DH
    Circulation; 1992 Sep; 86(3):858-69. PubMed ID: 1516198
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipid profiles and risk of major adverse cardiovascular events in CKD and diabetes: A nationwide population-based study.
    Lee Y; Park S; Lee S; Kim Y; Kang MW; Cho S; Park S; Han K; Kim YC; Han SS; Lee H; Lee JP; Joo KW; Lim CS; Kim YS; Kim DK
    PLoS One; 2020; 15(4):e0231328. PubMed ID: 32271842
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Remnant Cholesterol, Not LDL Cholesterol, Is Associated With Incident Cardiovascular Disease.
    Castañer O; Pintó X; Subirana I; Amor AJ; Ros E; Hernáez Á; Martínez-González MÁ; Corella D; Salas-Salvadó J; Estruch R; Lapetra J; Gómez-Gracia E; Alonso-Gomez AM; Fiol M; Serra-Majem L; Corbella E; Benaiges D; Sorli JV; Ruiz-Canela M; Babió N; Sierra LT; Ortega E; Fitó M
    J Am Coll Cardiol; 2020 Dec; 76(23):2712-2724. PubMed ID: 33272365
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low high-density lipoprotein cholesterol and other coronary heart disease risk factors in patients with total cholesterol levels greater than 5.17 mmol/L (200 mg/dL) in family practice. A report from CEN.
    J Am Board Fam Pract; 1991; 4(5):285-97. PubMed ID: 1746296
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Associations between serum high-density lipoprotein cholesterol levels and cause-specific mortality in a general population of 345 000 men and women aged 20-79 years.
    Mørland JG; Magnus P; Vollset SE; Leon DA; Selmer R; Tverdal A
    Int J Epidemiol; 2023 Aug; 52(4):1257-1267. PubMed ID: 36779319
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lowering Targeted Atherogenic Lipoprotein Cholesterol Goals for Patients at "Extreme" ASCVD Risk.
    Rosenblit PD
    Curr Diab Rep; 2019 Nov; 19(12):146. PubMed ID: 31754844
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extreme high high-density lipoprotein cholesterol is paradoxically associated with high mortality in men and women: two prospective cohort studies.
    Madsen CM; Varbo A; Nordestgaard BG
    Eur Heart J; 2017 Aug; 38(32):2478-2486. PubMed ID: 28419274
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of extremely high levels of high-density lipoprotein cholesterol with cardiovascular mortality in a pooled analysis of 9 cohort studies including 43,407 individuals: The EPOCH-JAPAN study.
    Hirata A; Sugiyama D; Watanabe M; Tamakoshi A; Iso H; Kotani K; Kiyama M; Yamada M; Ishikawa S; Murakami Y; Miura K; Ueshima H; Okamura T;
    J Clin Lipidol; 2018; 12(3):674-684.e5. PubMed ID: 29506864
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Very high high-density lipoprotein cholesterol is associated with increased all-cause mortality in South Koreans.
    Oh IH; Hur JK; Ryoo JH; Jung JY; Park SK; Yang HJ; Choi JM; Jung KW; Won YJ; Oh CM
    Atherosclerosis; 2019 Apr; 283():43-51. PubMed ID: 30776703
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma lipoprotein levels as predictors of cardiovascular death in women.
    Bass KM; Newschaffer CJ; Klag MJ; Bush TL
    Arch Intern Med; 1993 Oct; 153(19):2209-16. PubMed ID: 8215724
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of low high-density lipoprotein-cholesterol level on 2-year clinical outcomes after acute myocardial infarction in patients with diabetes mellitus.
    Joo HJ; Cho SA; Hong SJ; Hur SH; Bae JH; Choi DJ; Ahn YK; Park JS; Choi RK; Choi D; Kim JH; Han KR; Park HS; Choi SY; Yoon JH; Kwon HC; Rha SW; Hwang KK; Jung KT; Oh SK; Lee JH; Shin ES; Kim KS; Kim HS; Lim DS
    Lipids Health Dis; 2016 Nov; 15(1):197. PubMed ID: 27863493
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of combination therapy with lipid-reducing drugs in patients with coronary heart disease and "normal" cholesterol levels. A randomized, placebo-controlled trial. Harvard Atherosclerosis Reversibility Project (HARP) Study Group.
    Pasternak RC; Brown LE; Stone PH; Silverman DI; Gibson CM; Sacks FM
    Ann Intern Med; 1996 Oct; 125(7):529-40. PubMed ID: 8815751
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between high-density lipoprotein cholesterol levels and major adverse cardiovascular events in patients who underwent coronary computed tomography angiography: FU-CCTA registry.
    Kawahira Y; Shiga Y; Inoue H; Suematsu Y; Tashiro K; Kato Y; Fujimi K; Takamiya Y; Kuwano T; Sugihara M; Miura SI
    Heart Vessels; 2021 Oct; 36(10):1457-1465. PubMed ID: 33744994
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of niacin in raising high-density lipoprotein cholesterol to reduce cardiovascular events in patients with atherosclerotic cardiovascular disease and optimally treated low-density lipoprotein cholesterol: baseline characteristics of study participants. The Atherothrombosis Intervention in Metabolic syndrome with low HDL/high triglycerides: impact on Global Health outcomes (AIM-HIGH) trial.
    AIM-HIGH Investigators
    Am Heart J; 2011 Mar; 161(3):538-43. PubMed ID: 21392609
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Lipid risk factors of coronary heart disease during longterm observation of a Warsaw Pol-Monica population-based cohort].
    Chotkowska E; Jasiński B; Kupść W; Broda G
    Pol Arch Med Wewn; 1997 Jan; 97(1):37-46. PubMed ID: 9235550
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nonoptimal lipids commonly present in young adults and coronary calcium later in life: the CARDIA (Coronary Artery Risk Development in Young Adults) study.
    Pletcher MJ; Bibbins-Domingo K; Liu K; Sidney S; Lin F; Vittinghoff E; Hulley SB
    Ann Intern Med; 2010 Aug; 153(3):137-46. PubMed ID: 20679558
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between lipid levels and major adverse cardiovascular events in rheumatoid arthritis compared to non-rheumatoid arthritis patients.
    Liao KP; Liu J; Lu B; Solomon DH; Kim SC
    Arthritis Rheumatol; 2015 May; 67(8):2004-10. PubMed ID: 25917955
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.